Obstetrx creates a uterine tamponade device to eliminate maternal death and disability from postpartum hemorrhage. In 2014, RevMedx, Inc.
developed the XSTAT® hemorrhage-control device in concert with the US military to stop severe bleeding from non-compressible wounds suffered on the battlefield. StoryHouse is evaluating the Pre-Round.
Andrew Barofsky responded to Keith's follow-up legal questions on the XSTAT PPH invention and license provisions.
Expert user opinion (via Kenton Gregory) on the in-uterine tamponade device.
Kenton Gregory's introduction following a Claremont Funder/Founder event.
2026-05-19: Reference involving Kenton Gregory. ### INTRO AND INTEL SOURCE: ### Through Kenton Gregory from ObstetRx ### ### DEAL STATUS: ### In Conversation ### ### NEXT STEPS: ### Internal discussion on scope of further DD or not. ### ### SUMMARY OF CALL: ### Expert...